There are a number of exciting technological advances that could change diabetes care as we know it, such as improved continuous glucose monitors and convenient decision support tools, said Robert Gabbay, MD, PhD, chief medical officer of the Joslin Diabetes Center.
There are a number of exciting technological advances that could change diabetes care as we know it, such as improved continuous glucose monitors and convenient decision support tools, said Robert Gabbay, MD, PhD, chief medical officer of the Joslin Diabetes Center.
Transcript (slightly modified)
What developments in diabetes technology will we see in the next year after the American Diabetes Association Scientific Sessions?
Diabetes technology is about to explode in terms of its impact on diabetes care, and I think there are a few different ways that’s going to happen. One is in the realm of continuous glucose monitors; they’re about to become cheaper, more accurate, and a new one on the market that doesn’t require calibration, ultimately has the potential if it’s inexpensive enough to replace blood glucose monitoring as we know it with a lot more information. That added information could be used to help drive better outcomes for patients with diabetes, so that’s one big exciting area of technology.
The second one I’ll mention is using that continuous glucose data to drive insulin pump changes, and the first step of that is the Medtronic 670G, which will allow titration of insulin through the pump overnight to maintain near-normal glucose levels. It’ll be a self-regulating system, the first time that’s really been available. Initially it’ll be only for a small subset of people, mostly those with type 1 and some with type 2 that are on insulin pumps, but I think that technology will continue to evolve and improve and become more widely available.
The third area that I’ll mention that I think is also very exciting is the decision support tools and the ability to provide real-time information to patients, but also potentially to providers on how to better manage patients, and for patients how to better care for themselves. Being able to capture all the information—glucose levels, activity levels through step counting and other mechanisms, and dietary information—all on somebody’s smartphone to help guide and coach them towards a better lifestyle could be very effective. Similarly, that information transmitted to providers in an intelligible and actionable way could also drive better care.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More